Amgen Warns Of 'Chaos' In High Court Biosimilar Clash
Amgen told the U.S. Supreme Court on Friday that biosimilar makers must divulge approval applications to innovator rivals and wait for product approval before giving the required notice of sales, warning...To view the full article, register now.
Already a subscriber? Click here to view full article